Page last updated: 2024-10-31

mitoxantrone and Jaw Diseases

mitoxantrone has been researched along with Jaw Diseases in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Jaw Diseases: Diseases involving the JAW.

Research Excerpts

ExcerptRelevanceReference
"The case of a 58-year-old female with breast cancer who developed multiple and ultimately fatal metastases despite 3 years of treatment with chemotherapeutic drugs and intravenous bisphosphonates, is presented herein."5.43Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws. ( Bagan, JV; Bagan, L; Poveda, R; Scully, C, 2016)
"The case of a 58-year-old female with breast cancer who developed multiple and ultimately fatal metastases despite 3 years of treatment with chemotherapeutic drugs and intravenous bisphosphonates, is presented herein."1.43Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws. ( Bagan, JV; Bagan, L; Poveda, R; Scully, C, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagan, JV1
Bagan, L1
Poveda, R1
Scully, C1

Other Studies

1 other study available for mitoxantrone and Jaw Diseases

ArticleYear
Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws.
    International journal of oral and maxillofacial surgery, 2016, Volume: 45, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Fatal Outcome; Female; Humans; Jaw Diseases; Middle Aged; M

2016